位置:首页 > 蛋白库 > ARSG_MOUSE
ARSG_MOUSE
ID   ARSG_MOUSE              Reviewed;         525 AA.
AC   Q3TYD4; B1AT67; B1AT68; Q5XFU5; Q69ZT6; Q8CHS3; Q8VBZ5; Q9D3B4;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   03-AUG-2022, entry version 123.
DE   RecName: Full=Arylsulfatase G;
DE            Short=ASG;
DE            EC=3.1.6.1 {ECO:0000269|PubMed:25135642};
DE   AltName: Full=N-sulfoglucosamine-3-sulfatase;
DE            EC=3.1.6.15 {ECO:0000269|PubMed:22689975};
DE   Flags: Precursor;
GN   Name=Arsg; Synonyms=Kiaa1001;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Medulla oblongata, and Visual cortex;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J, and FVB/N; TISSUE=Brain, Kidney, and Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 14-525 (ISOFORM 1).
RX   PubMed=15368895; DOI=10.1093/dnares/11.3.205;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Seino S., Nishimura M., Kaisho T., Hoshino K., Kitamura H.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: IV.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 11:205-218(2004).
RN   [5]
RP   IDENTIFICATION.
RX   PubMed=16174644; DOI=10.1093/hmg/ddi351;
RA   Sardiello M., Annunziata I., Roma G., Ballabio A.;
RT   "Sulfatases and sulfatase modifying factors: an exclusive and promiscuous
RT   relationship.";
RL   Hum. Mol. Genet. 14:3203-3217(2005).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=22689975; DOI=10.1073/pnas.1202071109;
RA   Kowalewski B., Lamanna W.C., Lawrence R., Damme M., Stroobants S.,
RA   Padva M., Kalus I., Frese M.A., Luebke T., Luellmann-Rauch R., D'Hooge R.,
RA   Esko J.D., Dierks T.;
RT   "Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase
RT   activity and mucopolysaccharidosis in mice.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:10310-10315(2012).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PROTEOLYTIC CLEAVAGE,
RP   GLYCOSYLATION AT ASN-117; ASN-215; ASN-356 AND ASN-497, AND MUTAGENESIS OF
RP   ASN-117; ASN-215; ASN-356 AND ASN-497.
RX   PubMed=25135642; DOI=10.1074/jbc.m114.584144;
RA   Kowalewski B., Luebke T., Kollmann K., Braulke T., Reinheckel T.,
RA   Dierks T., Damme M.;
RT   "Molecular characterization of arylsulfatase G: expression, processing,
RT   glycosylation, transport, and activity.";
RL   J. Biol. Chem. 289:27992-28005(2014).
CC   -!- FUNCTION: Displays arylsulfatase activity at acidic pH towards the
CC       artificial substrate p-nitrocatechol sulfate (PubMed:25135642).
CC       Catalyzes the hydrolysis of the 3-sulfate groups of the N-sulfo-D-
CC       glucosamine 3-O-sulfate units of heparin (PubMed:22689975).
CC       {ECO:0000269|PubMed:22689975, ECO:0000269|PubMed:25135642}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aryl sulfate + H2O = a phenol + H(+) + sulfate;
CC         Xref=Rhea:RHEA:17261, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16189, ChEBI:CHEBI:33853, ChEBI:CHEBI:140317; EC=3.1.6.1;
CC         Evidence={ECO:0000269|PubMed:25135642};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolysis of the 3-sulfate groups of the N-sulfo-D-
CC         glucosamine 3-O-sulfate units of heparin.; EC=3.1.6.15;
CC         Evidence={ECO:0000269|PubMed:22689975};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:P15289};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250|UniProtKB:P15289};
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:25135642}. Note=The
CC       63-kDa precursor protein localizes to pre-lysosomal compartments and
CC       tightly associates with organelle membranes, most likely the
CC       endoplasmic reticulum. In contrast, proteolytically processed fragments
CC       of 34-, 18- and 10-kDa are found in lysosomal fractions and lose their
CC       membrane association. {ECO:0000269|PubMed:25135642}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q3TYD4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q3TYD4-2; Sequence=VSP_018628, VSP_018629;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the spleen, kidney, liver,
CC       brain, and testis (at protein level). {ECO:0000269|PubMed:25135642}.
CC   -!- PTM: N-glycosylated with both high mannose and complex type sugars.
CC       {ECO:0000269|PubMed:25135642}.
CC   -!- PTM: The conversion to 3-oxoalanine (also known as C-formylglycine,
CC       FGly), of a serine or cysteine residue in prokaryotes and of a cysteine
CC       residue in eukaryotes, is critical for catalytic activity.
CC       {ECO:0000250|UniProtKB:P15289}.
CC   -!- PTM: The 63-kDa precursor undergoes proteolytic processing in two
CC       steps, yielding two fragments in the first step (apparent molecular
CC       masses of 44 and 18 kDa). In the second step, the 44-kDa fragment is
CC       processed further to the 34- and 10-kDa chains. The 10-kDa chain is a
CC       cleavage product of the 44-kDa fragment but linked to the 18-kDa chain
CC       through a disulfide bridge. {ECO:0000269|PubMed:25135642}.
CC   -!- DISRUPTION PHENOTYPE: Mice accumulate heparan sulfate in visceral
CC       organs and the central nervous system and develop neuronal cell death
CC       and behavioral deficits (PubMed:22689975). This accumulated heparan
CC       sulfate exhibits unique non-reducing end structures with terminal N-
CC       sulfoglucosamine-3-O-sulfate residues (PubMed:22689975).
CC       {ECO:0000269|PubMed:22689975}.
CC   -!- SIMILARITY: Belongs to the sulfatase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK018132; BAB31086.1; -; mRNA.
DR   EMBL; AK158726; BAE34629.1; -; mRNA.
DR   EMBL; AL645791; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022158; AAH22158.1; -; mRNA.
DR   EMBL; BC039629; AAH39629.1; -; mRNA.
DR   EMBL; BC084731; AAH84731.1; -; mRNA.
DR   EMBL; AK173082; BAD32360.1; -; mRNA.
DR   EMBL; BN000747; CAI84993.1; -; mRNA.
DR   CCDS; CCDS25581.1; -. [Q3TYD4-1]
DR   CCDS; CCDS48971.1; -. [Q3TYD4-2]
DR   RefSeq; NP_001159649.1; NM_001166177.1. [Q3TYD4-2]
DR   RefSeq; NP_082986.3; NM_028710.3. [Q3TYD4-1]
DR   RefSeq; XP_006534411.1; XM_006534348.2. [Q3TYD4-1]
DR   RefSeq; XP_006534412.1; XM_006534349.3. [Q3TYD4-1]
DR   RefSeq; XP_006534413.1; XM_006534350.3. [Q3TYD4-1]
DR   RefSeq; XP_017170289.1; XM_017314800.1. [Q3TYD4-1]
DR   RefSeq; XP_017170290.1; XM_017314801.1.
DR   AlphaFoldDB; Q3TYD4; -.
DR   SMR; Q3TYD4; -.
DR   BioGRID; 216419; 1.
DR   STRING; 10090.ENSMUSP00000102307; -.
DR   GlyConnect; 2135; 4 N-Linked glycans (1 site).
DR   GlyGen; Q3TYD4; 2 sites, 4 N-linked glycans (1 site).
DR   PhosphoSitePlus; Q3TYD4; -.
DR   MaxQB; Q3TYD4; -.
DR   PaxDb; Q3TYD4; -.
DR   PeptideAtlas; Q3TYD4; -.
DR   PRIDE; Q3TYD4; -.
DR   ProteomicsDB; 265106; -. [Q3TYD4-1]
DR   ProteomicsDB; 265107; -. [Q3TYD4-2]
DR   Antibodypedia; 19259; 189 antibodies from 23 providers.
DR   DNASU; 74008; -.
DR   Ensembl; ENSMUST00000020928; ENSMUSP00000020928; ENSMUSG00000020604. [Q3TYD4-1]
DR   Ensembl; ENSMUST00000106696; ENSMUSP00000102307; ENSMUSG00000020604. [Q3TYD4-2]
DR   Ensembl; ENSMUST00000106697; ENSMUSP00000102308; ENSMUSG00000020604. [Q3TYD4-1]
DR   GeneID; 74008; -.
DR   KEGG; mmu:74008; -.
DR   UCSC; uc007mcn.1; mouse. [Q3TYD4-1]
DR   UCSC; uc007mcp.2; mouse. [Q3TYD4-2]
DR   CTD; 22901; -.
DR   MGI; MGI:1921258; Arsg.
DR   VEuPathDB; HostDB:ENSMUSG00000020604; -.
DR   eggNOG; KOG3867; Eukaryota.
DR   GeneTree; ENSGT00940000159093; -.
DR   HOGENOM; CLU_006332_13_6_1; -.
DR   InParanoid; Q3TYD4; -.
DR   OMA; PFTGLWQ; -.
DR   OrthoDB; 515367at2759; -.
DR   PhylomeDB; Q3TYD4; -.
DR   BRENDA; 3.1.6.1; 3474.
DR   Reactome; R-MMU-1660662; Glycosphingolipid metabolism.
DR   Reactome; R-MMU-1663150; The activation of arylsulfatases.
DR   BioGRID-ORCS; 74008; 3 hits in 69 CRISPR screens.
DR   ChiTaRS; Arsg; mouse.
DR   PRO; PR:Q3TYD4; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q3TYD4; protein.
DR   Bgee; ENSMUSG00000020604; Expressed in lumbar subsegment of spinal cord and 153 other tissues.
DR   Genevisible; Q3TYD4; MM.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:HGNC-UCL.
DR   GO; GO:0005615; C:extracellular space; ISO:MGI.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0004065; F:arylsulfatase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0033889; F:N-sulfoglucosamine-3-sulfatase activity; IMP:UniProtKB.
DR   GO; GO:0006790; P:sulfur compound metabolic process; ISO:MGI.
DR   Gene3D; 3.40.720.10; -; 1.
DR   InterPro; IPR017850; Alkaline_phosphatase_core_sf.
DR   InterPro; IPR024607; Sulfatase_CS.
DR   InterPro; IPR000917; Sulfatase_N.
DR   Pfam; PF00884; Sulfatase; 1.
DR   SUPFAM; SSF53649; SSF53649; 1.
DR   PROSITE; PS00523; SULFATASE_1; 1.
DR   PROSITE; PS00149; SULFATASE_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Disulfide bond; Glycoprotein; Hydrolase;
KW   Lysosome; Metal-binding; Reference proteome; Signal.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000255"
FT   CHAIN           17..525
FT                   /note="Arylsulfatase G"
FT                   /id="PRO_0000238663"
FT   ACT_SITE        84
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   ACT_SITE        139
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   BINDING         44
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   BINDING         45
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   BINDING         84
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /note="via 3-oxoalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   BINDING         137
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   BINDING         162
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   BINDING         251
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   BINDING         302
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   BINDING         303
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   MOD_RES         84
FT                   /note="3-oxoalanine (Cys)"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   CARBOHYD        117
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25135642"
FT   CARBOHYD        215
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25135642"
FT   CARBOHYD        356
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25135642"
FT   CARBOHYD        497
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25135642"
FT   VAR_SEQ         1..323
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018628"
FT   VAR_SEQ         324..327
FT                   /note="QTHQ -> MIKI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018629"
FT   MUTAGEN         117
FT                   /note="N->Q: Faster electrophoretic migration typical of a
FT                   size reduction probably due to glycosylation loss."
FT                   /evidence="ECO:0000269|PubMed:25135642"
FT   MUTAGEN         215
FT                   /note="N->Q: Faster electrophoretic migration typical of a
FT                   size reduction probably due to glycosylation loss."
FT                   /evidence="ECO:0000269|PubMed:25135642"
FT   MUTAGEN         356
FT                   /note="N->Q: Faster electrophoretic migration typical of a
FT                   size reduction probably due to glycosylation loss."
FT                   /evidence="ECO:0000269|PubMed:25135642"
FT   MUTAGEN         497
FT                   /note="N->Q: Faster electrophoretic migration typical of a
FT                   size reduction probably due to glycosylation loss.
FT                   Abolishes proteolytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:25135642"
FT   CONFLICT        122
FT                   /note="A -> V (in Ref. 3; AAH84731)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="L -> Q (in Ref. 1; BAB31086)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   525 AA;  57434 MW;  FA319206459D1B2B CRC64;
     MGWLFLKVLL VGMAFSGFFY PLVDFSISGK TRAPQPNIVI ILADDMGWGD LGANWAETKD
     TTNLDKMASE GMRFVDFHAA ASTCSPSRAS LLTGRLGLRN GVTHNFAVTS VGGLPVNETT
     LAEVLRQEGY VTAMIGKWHL GHHGSYHPNF RGFDYYFGIP YSNDMGCTDA PGYNYPPCPA
     CPQRDGLWRN PGRDCYTDVA LPLYENLNIV EQPVNLSGLA QKYAERAVEF IEQASTSGRP
     FLLYVGLAHM HVPLSVTPPL AHPQRQSLYR ASLREMDSLV GQIKDKVDHV ARENTLLWFT
     GDNGPWAQKC ELAGSVGPFF GLWQTHQGGS PTKQTTWEGG HRVPALAYWP GRVPANVTST
     ALLSLLDIFP TVIALAGASL PPNRKFDGRD VSEVLFGKSQ MGHRVLFHPN SGAAGEYGAL
     QTVRLNHYKA FYITGGAKAC DGSVGPEQHH VAPLIFNLED AADEGMPLQK GSPEYQEVLQ
     QVTRALADVL QDIADDNSSR ADYTQDPSVI PCCNPYQTTC RCQPV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024